Literature DB >> 6255607

Impact of Hodgkin's disease upon the immune system.

J J Twomey, L Rice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6255607

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  9 in total

1.  Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.

Authors:  F Griesinger; L Bergmann; R Barot-Ciorbaru; P S Mitrou
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission.

Authors:  A M Liberati; M Brugia; B S Edwards; P Bertoni; E Ballatori; A Puxeddu; F Grignani
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.

Authors:  M E Kadin; B A Agnarsson; L R Ellingsworth; S R Newcom
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

4.  Natural killer (NK) activity in the spleen of patients with Hodgkin's disease and controls.

Authors:  S Al Sam; D B Jones; S V Payne; D H Wright
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

5.  The distribution of iron and iron binding proteins in spleen with reference to Hodgkin's disease.

Authors:  K J Britten; D B Jones; M De Sousa; D H Wright
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

6.  Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.

Authors:  C Wedelin; M Björkholm; G Holm; S Ogenstad; B Johansson; H Mellstedt
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

7.  Mutagenesis after cancer therapy.

Authors:  K T Kelsey; M Caggana; P M Mauch; C N Coleman; J R Clark; H L Liber
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

8.  Hodgkin's disease: subsequent primary cancers in relation to treatment.

Authors:  P Prior; D J Pope
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

9.  Missed irradiation of cellular blood components for vulnerable patients: Insights from 10 years of SHOT data.

Authors:  Johnathon Elliot; Shruthi Narayan; Debbi Poles; Victoria Tuckley; Paula H B Bolton-Maggs
Journal:  Transfusion       Date:  2020-11-21       Impact factor: 3.157
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.